{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:48:15Z","timestamp":1767908895676,"version":"3.49.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/spc.0b013e32834f6a07","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T21:24:06Z","timestamp":1371158646000},"page":"10-16","source":"Crossref","is-referenced-by-count":9,"title":["Opioid genetics in the context of opioid switching"],"prefix":"10.1097","volume":"6","author":[{"given":"Joanne","family":"Droney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20211004","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/0269216311401948","article-title":"A systematic review of oxycodone in the management of cancer pain.","volume":"25","author":"King","year":"2011","journal-title":"Palliat Med"},{"key":"R2-3-20211004","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/0269216310387962","article-title":"The role of hydromorphone in cancer pain treatment: a systematic review.","volume":"25","author":"Pigni","year":"2011","journal-title":"Palliat Med"},{"key":"R3-3-20211004","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/0269216311404274","article-title":"Transdermal opioids as front line treatment of moderate to severe cancer pain: a systemic review.","volume":"25","author":"Tassinari","year":"2011","journal-title":"Palliat Med"},{"key":"R5-3-20211004","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1185\/03007995.2011.586332","article-title":"Can morphine still be considered to be the standard for treating chronic pain A systematic review including pair-wise and network meta-analyses.","volume":"27","author":"Bekkering","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"R6-3-20211004","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/0269216310392102","article-title":"Is oral morphine still the first choice opioid for moderate to severe cancer pain A systematic review within the European Palliative Care Research Collaborative guidelines project.","volume":"25","author":"Caraceni","year":"2011","journal-title":"Palliat Med"},{"key":"R8-3-20211004","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain.","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"key":"R9-3-20211004","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neuron.2006.10.006","article-title":"SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.","volume":"52","author":"Fertleman","year":"2006","journal-title":"Neuron"},{"key":"R10-3-20211004","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.cell.2009.04.019","article-title":"Dissociation of the opioid receptor mechanisms that control mechanical and heat pain.","volume":"137","author":"Scherrer","year":"2009","journal-title":"Cell"},{"key":"R12-3-20211004","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpain.2009.04.001","article-title":"Genetic contributions to clinical pain and analgesia: avoiding pitfalls in genetic research.","volume":"10","author":"Kim","year":"2009","journal-title":"J Pain"},{"key":"R13-3-20211004","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/rheumatology\/keq170","article-title":"Pain reporting at different body sites is explained by a single underlying genetic factor.","volume":"49","author":"Williams","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R14-3-20211004","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1136\/ard.2010.137836","article-title":"Lumbar disc degeneration and genetic factors are the main risk factors for low back pain in women: the UK Twin Spine Study.","volume":"70","author":"Livshits","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R15-3-20211004","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/art.24607","article-title":"Heritability of spinal pain and consequences of spinal pain: a comprehensive genetic epidemiologic analysis using a population-based sample of 15,328 twins ages 20-71 years.","volume":"61","author":"Hartvigsen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R17-3-20211004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pain.2007.06.008","article-title":"Individual differences in pain sensitivity: genetic and environmental contributions.","volume":"136","author":"Nielsen","year":"2008","journal-title":"Pain"},{"key":"R18-3-20211004","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1375\/twin.13.5.412","article-title":"Opioid pharmacogenomics using a twin study paradigm: methods and procedures for determining familial aggregation and heritability.","volume":"13","author":"Angst","year":"2010","journal-title":"Twin Res Hum Genet"},{"key":"R20-3-20211004","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pain.2009.07.013","article-title":"Meta-analysis of the relevance of the OPRM1 118AG genetic variant for pain treatment.","volume":"146","author":"Walter","year":"2009","journal-title":"Pain"},{"key":"R21-3-20211004","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/FPC.0b013e32832b89da","article-title":"Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.","volume":"19","author":"Lotsch","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"R23-3-20211004","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/hmg\/ddn439","article-title":"Expansion of the human micro-opioid receptor gene architecture: novel functional variants.","volume":"18","author":"Shabalina","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R24-3-20211004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pain.2009.10.021","article-title":"A GTP cyclohydrolase 1 genetic variant delays cancer pain.","volume":"148","author":"Lotsch","year":"2011","journal-title":"Pain"},{"key":"R25-3-20211004","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/AJP.0b013e3181b43e12","article-title":"Cross-sectional assessment of the consequences of a GTP cyclohydrolase 1 haplotype for specialized tertiary outpatient pain care.","volume":"25","author":"Doehring","year":"2009","journal-title":"Clin J Pain"},{"key":"R26-3-20211004","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clon.2011.04.015","article-title":"Evolving knowledge of opioid genetics in cancer pain.","volume":"23","author":"Droney","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R27-3-20211004","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tips.2010.04.002","article-title":"A critical appraisal of human genotyping for pain therapy.","volume":"31","author":"Lotsch","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"R28-3-20211004","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.ejca.2011.04.014","article-title":"Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.","volume":"47","author":"Laugsand","year":"2011","journal-title":"Eur J Cancer"},{"key":"R30-3-20211004","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1158\/1078-0432.CCR-10-3028","article-title":"Multiple loci modulate opioid therapy response for cancer pain.","volume":"17","author":"Galvan","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R31-3-20211004","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.pain.2011.01.040","article-title":"Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.","volume":"152","author":"Klepstad","year":"2011","journal-title":"Pain"},{"key":"R32-3-20211004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2217\/14622416.10.2.171","article-title":"Genome-wide association study of acute postsurgical pain in humans.","volume":"10","author":"Kim","year":"2009","journal-title":"Pharmacogenomics"},{"key":"R34-3-20211004","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tig.2007.09.004","article-title":"Genetic architecture of human pain perception.","volume":"23","author":"Diatchenko","year":"2007","journal-title":"Trends Genet"},{"key":"R35-3-20211004","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1213\/ANE.0b013e318202cc8d","article-title":"Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects.","volume":"112","author":"Kolesnikov","year":"2011","journal-title":"Anesth Analg"},{"key":"R36-3-20211004","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.clpt.6100385","article-title":"Association of ABCB1MDR1 and OPRM1 gene polymorphisms with morphine pain relief.","volume":"83","author":"Campa","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R37-3-20211004","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/cncr.23292","article-title":"Genetic variation and response to morphine in cancer patients: catechol-o-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects.","volume":"112","author":"Ross","year":"2008","journal-title":"Cancer"},{"key":"R38-3-20211004","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1471-2105-12-364","article-title":"Characterizing genetic interactions in human disease association studies using statistical epistasis networks.","volume":"12","author":"Hu","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"R40-3-20211004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature07331","article-title":"Genes mirror geography within Europe.","volume":"456","author":"Novembre","year":"2008","journal-title":"Nature"},{"key":"R41-3-20211004","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/447655a","article-title":"Replicating genotype-phenotype associations.","volume":"447","author":"Chanock","year":"2007","journal-title":"Nature"},{"key":"R42-3-20211004","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jpainsymman.2010.08.016","article-title":"Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review.","volume":"41","author":"Hjermstad","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"R44-3-20211004","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000326085","article-title":"CYP2D6 in the metabolism of opioids for mild to moderate pain.","volume":"87","author":"Leppert","year":"2011","journal-title":"Pharmacology"},{"key":"R45-3-20211004","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1133807","article-title":"HTRA1 promoter polymorphism in wet age-related macular degeneration.","volume":"314","author":"Dewan","year":"2006","journal-title":"Science"},{"key":"R46-3-20211004","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1200\/JCO.2004.07.173","article-title":"Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.","volume":"22","author":"Innocenti","year":"2004","journal-title":"J Clin Oncol"},{"key":"R47-3-20211004","doi-asserted-by":"crossref","first-page":"e17387","DOI":"10.1371\/journal.pone.0017387","article-title":"Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients.","volume":"6","author":"Binder","year":"2011","journal-title":"PLoS One"},{"key":"R48-3-20211004","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1093\/nar\/gkr165","article-title":"Disruptive mRNA folding increases translational efficiency of catechol-O-methyltransferase variant.","volume":"39","author":"Tsao","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"R49-3-20211004","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1073\/pnas.0913181107","article-title":"Pain perception is altered by a nucleotide polymorphism in SCN9A.","volume":"107","author":"Reimann","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R50-3-20211004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pnpbp.2011.08.013","article-title":"Should pharmacogenetics be incorporated in major depression treatment Economic evaluation in high- and middle-income European countries.","volume":"36","author":"Olgiati","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R51-3-20211004","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0269216310384902","article-title":"European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review.","volume":"25","author":"Dale","year":"2011","journal-title":"Palliat Med"},{"key":"R52-3-20211004","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jpainsymman.2007.12.024","article-title":"Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.","volume":"37","author":"Mercadante","year":"2009","journal-title":"J Pain Symptom Manage"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201203000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T02:12:31Z","timestamp":1633313551000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201203000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0b013e32834f6a07","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}